Ouabain enhances basal and stimulus-induced cytoplasmic calcium concentrations in platelets.

Abstract:

:Incubation of platelet-rich plasma (PRP) with ouabain, an inhibitor of sodium/potassium ATPase (Na+/K+ ATPase), induced a significant rise in basal platelet intracellular calcium concentration [( Ca2+]i) when measured using fura 2. Ouabain induced an enhanced aggregation response to low doses of collagen in both PRP and washed platelets loaded with aequorin. In aequorin loaded platelets this enhanced aggregation response was associated with an enhanced rise in [Ca2+]i such that the relationship between [Ca2+]i and aggregation was unchanged. As inhibition of plasma membrane Na+/K+ ATPase would lead to a raised intracellular sodium ion concentration [( Na+]i) the results suggest that in the platelet, [Na+]i can modulate [Ca2+]i and hence influence the response of platelets to stimuli such as collagen.

journal_name

Thromb Haemost

authors

Lees AD,Wilson J,Orchard CH,Orchard MA

subject

Has Abstract

pub_date

1989-11-24 00:00:00

pages

1000-5

issue

3

eissn

0340-6245

issn

2567-689X

journal_volume

62

pub_type

杂志文章
  • Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay.

    abstract::We have developed a sensitive and quantitative RT-PCR assay for the determination of tissue factor (TF) mRNA levels in human cells. An in vitro synthesized internal standard RNA was used to correct for differences in reverse transcription or amplification of various RNA samples. The PCR products were quantitated by hy...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Pötgens AJ,Lubsen NH,van Altena G,Schoenmakers JG,Ruiter DJ,de Waal RM

    更新日期:1994-02-01 00:00:00

  • Heme oxygenase-1 inducer hemin prevents vascular thrombosis.

    abstract::Hemin is a heme oxygenase-1 (HO-1) inducer which provides endogenous carbon monoxide known for playing roles in cell proliferation, inflammation or aggregation process. The objective of the current study was to examine the effect of prophylactic treatment with hemin in a thrombosis vascular model. Three groups of Wist...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Desbuards N,Rochefort GY,Schlecht D,Machet MC,Halimi JM,Eder V,Hyvelin JM,Antier D

    更新日期:2007-09-01 00:00:00

  • Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.

    abstract::The efficacy of conventional dose adjusted oral anticoagulation for stroke prevention in patients with non-valvular atrial fibrillation is well-documented but not considered ideal as primary antithrombotic treatment in elderly patients. The antithrombotic effect of fixed minidose warfarin 1.25 mg/day alone or in combi...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Koefoed BG,Feddersen C,Gulløv AL,Petersen P

    更新日期:1997-05-01 00:00:00

  • In vivo plasminogen deficiency reduces fat accumulation.

    abstract::Obesity and non-insulin dependent diabetes are associated with a decrease in fibrinolysis, which is mediated by the plasminogen system. The purpose of the current study was to investigate the role of the plasminogen system in the reduced body weight of the plasminogen deficient (Plg-/-) mice. In this study we have fou...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Hoover-Plow J,Ellis J,Yuen L

    更新日期:2002-06-01 00:00:00

  • Angiotensin II enhances thrombosis development in renovascular hypertensive rats.

    abstract::There is an increased number of in vitro evidence that angiotensin II (Ang II) may promote thrombosis. However there are no in vivo experiments exploring the effect of Ang II on thrombus formation. In the present study we have investigated the influence of Ang II on venous thrombosis in renovascular hypertensive rats....

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-10-0701

    authors: Mogielnicki A,Chabielska E,Pawlak R,Szemraj J,Buczko W

    更新日期:2005-06-01 00:00:00

  • Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate.

    abstract::We performed experiments to determine whether endothelial cells synthesize phospholipid metabolites via the lipoxygenase pathway and whether these metabolites influence platelet/vessel wall interactions. Monolayers of cultured human endothelial cells were incubated with 14C-arachidonic acid and their cyclo-oxygenase a...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Buchanan MR,Butt RW,Magas Z,van Ryn J,Hirsh J,Nazir DJ

    更新日期:1985-06-24 00:00:00

  • Inhibitor to factor VIII in mild haemophilia.

    abstract::Factor VIII inhibitors in mild haemophilia are uncommon and the management of such patients is controversial. The development of a persistently high responding F VIII inhibitor in a mild haemophiliac is reported and the behaviour of the inhibitor discussed in the context of the various therapeutic regimes employed for...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Kesteven PJ,Holland LJ,Lawrie AS,Savidge GF

    更新日期:1984-08-31 00:00:00

  • Is EPCR a multi-ligand receptor? Pros and cons.

    abstract::In the last decade, the endothelial cell protein C/activated protein C receptor (EPCR) has received considerable attention. The role initially attributed to EPCR, i.e. the enhancement of protein C (PC) activation by the thrombin-thrombomodulin complex on the surface of the large vessels, although important, did not go...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH11-11-0766

    authors: Montes R,Puy C,Molina E,Hermida J

    更新日期:2012-05-01 00:00:00

  • On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.

    abstract:BACKGROUND: A strong association between on-thienopyridine platelet reactivity (PR) and the risk of both thrombotic and bleeding events in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) has been demonstrated. However, no study has analyzed the relationship between on-ticagrel...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1055/a-1326-5110

    authors: Laine M,Panagides V,Frère C,Cuisset T,Gouarne C,Jouve B,Lemesle G,Paganelli F,Alessi MC,Mancini J,Bonello L

    更新日期:2020-12-01 00:00:00

  • Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.

    abstract::Antithrombotic potency of recombinant hirudins rHV2, rHV2-Lys47 and rHV2-Arg47 was studied in a model of experimental thrombosis induced by tissue factor in the rat. Venous thrombosis was induced by i.v. injection of 25 mg/kg tissue factor followed by stasis of the inferior vena cava. In this model natural recombinant...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Freund M,Cazenave JP,Courtney M,Degryse E,Roitsch C,Bernat A,Delebassée D,Defreyn G,Maffrand JP

    更新日期:1990-04-12 00:00:00

  • Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.

    abstract:BACKGROUND: Cardiac-enriched micro ribonucleic acids (miRNAs) are released into the circulation following ST-elevation myocardial infarction (STEMI). Lack of standardized approaches for reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) data normalization and presence of RT-qPCR inhibitors...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1055/s-0038-1660437

    authors: Coelho-Lima J,Mohammed A,Cormack S,Jones S,Das R,Egred M,Panahi P,Ali S,Spyridopoulos I

    更新日期:2018-07-01 00:00:00

  • Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand disease.

    abstract::We have established a new analytical method which allows the characterization of von Willebrand factor (vWF) degradation fragments in minute amounts (10 microliters) of plasma, without the need for immunopurification of vWF. Plasma vWF was hydrolysed by S aureus V-8 protease (V-8 protease) and the cleaved fragments se...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Takahashi Y,Kalafatis M,Girma JP,Meyer D

    更新日期:1988-12-22 00:00:00

  • Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study.

    abstract::Emicizumab, a bispecific monoclonal antibody, bridges activated factor IX (FIXa) and FX, replacing the function of missing FVIIIa to restore effective hemostasis in persons with hemophilia A (PwHA). Here we assess pharmacokinetic (PK) and pharmacodynamic (PD) biomarkers in PwHA with FVIII inhibitors in the Phase III H...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1055/s-0040-1717114

    authors: Schmitt C,Adamkewicz JI,Xu J,Petry C,Catalani O,Young G,Negrier C,Callaghan MU,Levy GG

    更新日期:2020-10-21 00:00:00

  • Malondialdehyde production by platelets during secondary aggregation.

    abstract::A method is described for increasing the sensitivity of the thiobarbiturate assay for malondialdehyde by concentrating the coloured reaction product. The basal level of malondialdehyde-like material in plasma was found to be about 0.03 micrometer. Platelets synthesized malondialdehyde when stimulated by collagen or th...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: MacFarlane DE,Gardner S,Lipson C,Mills DC

    更新日期:1977-12-15 00:00:00

  • Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer.

    abstract::In a prospective study, coagulation test results were compared in 137 patients with colorectal cancer (CRC) and 39 subjects with benign colorectal diseases. Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT), and soluble fibrin (SF) were measured in plasma before and after surgery. CRC patients prese...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Iversen LH,Thorlacius-Ussing O

    更新日期:2002-03-01 00:00:00

  • Elimination of a human T-cell region in staphylokinase by T-cell screening and computer modeling.

    abstract::Staphylokinase is a potent highly fibrin-selective thrombolytic agent, but it induces a humoral immune response in most treated patients. Staphylokinase-specific T-lymphocytes can be found in normal healthy individuals, from whom a large panel of staphylokinase-specific T-cells were cloned. The staphylokinase amino ac...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Warmerdam PA,Plaisance S,Vanderlick K,Vandervoort P,Brepoels K,Collen D,De Maeyer M

    更新日期:2002-04-01 00:00:00

  • Ristocetin-induced platelet agglutination stimulates GPIIb/IIIa-dependent calcium influx.

    abstract::We found that intracellular Ca2+ concentration ([Ca2+]i) increased during ristocetin-induced agglutination of aequorin loaded platelets resuspended in plasma. Chelation of extracellular Ca2+ had no effect on platelet clumping, but delayed and greatly reduced Ca2+ increase, indicating that it derived for the most part ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Bertolino G,Noris P,Spedini P,Balduini CL

    更新日期:1995-04-01 00:00:00

  • Thrombophilic risk factors and peripheral arterial disease severity.

    abstract::Few data are available on thrombophilic risk factors and progression of atherosclerotic peripheral arterial disease (PAD). Thrombophilic alterations can be an aggravating factor when arterial stenoses are present. In a cross-sectional study, we evaluated the presence of the thrombophilic factors fibrinogen, homocystei...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH09-11-0772

    authors: Sartori M,Favaretto E,Legnani C,Cini M,Conti E,Amato A,Palareti G

    更新日期:2010-07-01 00:00:00

  • Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.

    abstract::In 70-80% of cases, pulmonary embolism is the consequence of lower extremity deep vein thrombosis. It has been demonstrated that the most common coagulation defect predisposing to venous thrombosis, resistance to activated protein C (APC), is not associated with an increased risk for pulmonary embolism, but the eviden...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Martinelli I,Cattaneo M,Panzeri D,Mannucci PM

    更新日期:1997-03-01 00:00:00

  • Fibrin glue for wound repair: facts and fancy.

    abstract::In wound repair, fibrin has a multiplicity of activities, some of which are intrinsic to the protein itself and some attributable to other blood constituents associated with the fibrin clot. Fibrin sealants, which have been approved for hemostasis in the US and Europe, are occasionally used wounds to promote healing. ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH03-08-0526

    authors: Clark RA

    更新日期:2003-12-01 00:00:00

  • Pathophysiological relevance of macrophage subsets in atherogenesis.

    abstract::Macrophages are highly heterogeneous and plastic cells. They were shown to play a critical role in all stages of atherogenesis, from the initiation to the necrotic core formation and plaque rupture. Lesional macrophages primarily derive from blood monocyte, but local macrophage proliferation as well as differentiation...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH16-08-0593

    authors: Liberale L,Dallegri F,Montecucco F,Carbone F

    更新日期:2017-01-05 00:00:00

  • Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.

    abstract::There is increasing concern that some anticoagulants can paradoxically increase thrombogenesis under certain circumstances. Previously, we demonstrated that at certain doses a direct thrombin inhibitor, melagatran, worsens the coagulation status induced by tissue factor (TF) injection in a rat model. We utilised an i...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH11-06-0382

    authors: Furugohri T,Sugiyama N,Morishima Y,Shibano T

    更新日期:2011-12-01 00:00:00

  • Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia.

    abstract::Cysteinyl leukotrienes (i.e. LTC4, LTD4), produced by activated leukocytes or by transcellular metabolism may act at different levels on vascular smooth muscle cells (VSMC) during inflammatory process or atherosclerosis. We studied the effect of LTC4, LTD4, and LTE4 on the in vitro proliferation of rat VSMC, measured ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Porreca E,Di Febbo C,Di Sciullo A,Angelucci D,Nasuti M,Vitullo P,Reale M,Conti P,Cuccurullo F,Poggi A

    更新日期:1996-07-01 00:00:00

  • Antithrombin III: a database of mutations.

    abstract::Elucidation of the molecular defects responsible for antithrombin III deficiency is proceeding rapidly. In order that a record is kept of the new and duplicated mutations that are found, we have compiled a database that we plan to update annually. In this, the first report of the database, we list 6 antithrombin III l...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Lane DA,Ireland H,Olds RJ,Thein SL,Perry DJ,Aiach M

    更新日期:1991-12-02 00:00:00

  • Thrombin generation in myocardial infarction and hypercholesterolemia: effects of aspirin.

    abstract::Over the last few years methods have been developed to assess appearance of thrombin during blood clotting in a clinical setting. This can be achieved either by measurement of the specific thrombin markers or by analysis of the thrombin generation kinetics. Thrombin markers rise following coronary occlusion and, surpr...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Szczeklik A

    更新日期:1995-07-01 00:00:00

  • Increased plasma thrombomodulin in cancer patients.

    abstract::Plasma samples from 35 patients with colorectal cancer, 16 patients with pancreatic cancer and 46 patients with various cancers in the terminal stage were analysed for soluble plasma thrombomodulin with an ELISA method. At time of diagnosis and before primary treatment, the patients with colorectal cancer had normal p...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Lindahl AK,Boffa MC,Abildgaard U

    更新日期:1993-02-01 00:00:00

  • Echinomycin suppresses the pyrogenic effects of endotoxin and interleukin-1 beta in human endothelial cells and peripheral blood mononuclear cells.

    abstract::Endotoxin (LPS) and interleukin-1 beta (IL-1 beta) increased in a dose-dependent manner the expression of tissue factor, an ubiquitous membrane-anchored glycoprotein that initiates blood coagulation at the surface of human umbilical vein endothelial cells (HUVEC and human peripheral blood mononuclear cells (PBMC). Ech...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Herbert JM,Lalé A,Pereillo JM,Derocq JM,Casellas P

    更新日期:1996-02-01 00:00:00

  • Edoxaban administration following enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects.

    abstract::Edoxaban is an oral direct factor (F)Xa inhibitor in advanced stages of clinical development. The primary objective of the present study was to assess the pharmacodynamics (PD) and safety of enoxaparin 1 mg/kg followed 12 hours (h) post-dose by edoxaban 60 mg, which is the regimen being used in the phase III study of ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,随机对照试验

    doi:10.1160/TH11-09-0676

    authors: Zahir H,Matsushima N,Halim AB,He L,Zhang G,Lee F,Worland V,Mendell J

    更新日期:2012-07-01 00:00:00

  • Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant.

    abstract::The presence of lupus anticoagulant (LA) predisposes to fetal loss and to venous and arterial thrombosis; however, a subgroup of women is unaffected by pregnancy loss. Currently, no predictive markers are available for the identification of women positive for LA at increased risk for pregnancy loss. It was the aim of ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Sailer T,Zoghlami C,Kurz C,Rumpold H,Quehenberger P,Panzer S,Pabinger I

    更新日期:2006-05-01 00:00:00

  • A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.

    abstract::The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with malignancy remains undefined. In particular, based on current evidence, it is uncertain whether secondary prophylaxis using standard intensity oral anticoagulant therapy is associated with higher risks of bleeding and recurrent thro...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Palareti G,Legnani C,Lee A,Manotti C,Hirsh J,D'Angelo A,Pengo V,Moia M,Coccheri S

    更新日期:2000-11-01 00:00:00